Global
smartphone
shipments
grew
5
percent
year-over-year
(YoY)
in
the
third
quarter
(Q3)
of
2024,
according
to
a
report
by
a
market
research
firm.
Samsung
maintained
its
position
as
the
original
equipment
manufacturer
with
the
highest
percentage
of
units
shipped,
whereas
Apple
and
Xiaomi
held
onto
their
rankings
from
the
last
quarter.
However,
all
three
of
them
registered
marginal
drops
in
the
market
share.
The
analysis
suggests
Vivo
also
recorded
a
positive
finish
to
the
quarter.
Global
Smartphone
Shipments
in
Q3
2024
A
report
by
market
analysis
firm
Canalys
reveals
Samsung
recorded
an
18
percent
share
in
smartphone
shipments
in
Q3
2024,
helping
it
achieve
the
top
spot.
The
South
Korean
technology
conglomerate
lost
a
three
percent
market
share
YoY.
The
same
goes
for
Apple,
which
registered
a
17
percent
market
share
in
this
quarter,
compared
to
its
18
percent
share
same
time
last
year.
The
iPhone
maker
finished
the
quarter
with
the
second
most
shipments.
As
per
Canalys,
this
is
Apple’s
third-highest
quarter
volume
to
date.
Some
contributing
factors
to
the
overall
growth
of
the
Cupertino-based
tech
giant
include
strong
demand
for
the
iPhone
15
series
and
previous
models.
The
analysis
emphasised
a
market
shift
towards
premium
devices,
especially
in
Apple’s
strong-hold
regions
like
Europe
and
North
America.
It
is
suggested
that
Apple’s
latest
smartphone
lineup
—
the
iPhone
16
series
—
may
not
only
help
it
to
a
strong
finish
in
Q4
2024
but
also
carry
the
moment
in
the
first
half
(H1)
of
2025.
Meanwhile,
Xiaomi
and
Oppo
grabbed
the
third
and
fourth
spots
on
the
list
with
14
and
nine
percent
market
shares,
respectively.
The
latter
was
helped
by
its
strong
performance
in
Indian
and
Latin
American
markets,
as
per
the
analysis.
Vivo
recorded
double-digit
growth
in
shipments
and
rounded
up
the
top
five,
finishing
with
a
nine
percent
market
share.
Canalys
reports
that
while
the
overall
market
conditions
are
improving,
the
demand
for
devices
remains
fragile.
This
is
due
to
global
challenges
including
demand
generation
and
regulatory
hurdles.